Saurav Chatterjee - 18 Feb 2023 Form 4 Insider Report for Augmedix, Inc. (AUGX)

Role
CHIEF TECHNOLOGY OFFICER
Signature
/s/ Todd Holvick, Attorney-in-Fact
Issuer symbol
AUGX
Transactions as of
18 Feb 2023
Transactions value $
$0
Form type
4
Filing time
22 Feb 2023, 20:07:43 UTC
Previous filing
11 Mar 2022
Next filing
27 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUGX Employee Stock Option (right to buy) Award $0 +70K $0.00 70K 18 Feb 2023 Common Stock 70K $1.79 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. The option will vest monthly in equal increments over four years starting on the grant date, subject to the Reporting Person's provision of service to the Issuer on each vesting date.